scholarly journals Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers

2019 ◽  
Vol 110 (8) ◽  
pp. 2667-2675 ◽  
Author(s):  
Akane Aikawa ◽  
Hideto Fujita ◽  
Takeo Kosaka ◽  
Hiroshi Minato ◽  
Etsuko Kiyokawa
Pathobiology ◽  
2008 ◽  
Vol 75 (5) ◽  
pp. 274-280 ◽  
Author(s):  
Zhen Sheng ◽  
Jiandong Wang ◽  
Yingchun Dong ◽  
Henghui Ma ◽  
Hangbo Zhou ◽  
...  

2019 ◽  
Vol 14 (3) ◽  
pp. 295-302 ◽  
Author(s):  
Giovanni Arpa ◽  
Federica Grillo ◽  
Paolo Giuffrida ◽  
Gabriella Nesi ◽  
Catherine Klersy ◽  
...  

Abstract Background and Aims Crohn’s disease-associated small bowel carcinoma is a rare event, usually reported to have a severe prognosis. However, in previous investigations we have found a minority of cases displaying a relatively favourable behaviour, thus outlining the need to improve the histopathological prediction of Crohn’s disease-associated small bowel carcinoma prognosis. Methods As in recent studies on colorectal cancer, a substantial improvement in prognostic evaluations has been provided by the histological analysis of the tumour invasive front; we therefore systematically analysed the tumour budding and poorly differentiated clusters in the invasive front of 47 Crohn’s disease-associated small bowel carcinomas collected through the Small Bowel Cancer Italian Consortium. Results Both tumour budding and poorly differentiated cluster analyses proved highly effective in prognostic evaluation of Crohn’s disease-associated small bowel carcinomas. In addition, they retained prognostic value when combined with two other parameters, i.e. glandular histology and stage I/II, both known to predict a relatively favourable small bowel carcinoma behaviour. In particular, association of tumour budding and poorly differentiated clusters in a combined invasive front score allowed identification of a minor subset of cancers [12/47, 25%] characterised by combined invasive front low grade coupled with a glandular histology and a low stage [I or II] and showing no cancer-related death during a median follow-up of 73.5 months. Conclusions The improved distinction of lower- from higher-grade Crohn’s disease-associated small bowel carcinomas provided by invasive front analysis should be of potential help in choosing appropriate therapy for these rare and frequently ominous neoplasms.


2006 ◽  
Vol 22 (5-6) ◽  
pp. 309-316 ◽  
Author(s):  
Jong-Shiaw Jin ◽  
Chi-Ying Wu ◽  
Yeh-Feng Lin ◽  
Jia-Yi Wang ◽  
Cheng-Ping Yu ◽  
...  

Aim: Extracellular matrix metalloprotease inducer (EMMPRIN) expression was demonstrated in several cancers, but its expression profile in colorectal cancers remains unclear. Epidermal growth factor receptor (EGFR) was reported to regulate EMMPRIN expression in human epithelial cancers. Our purpose was to determine EMMPRIN expression and its relationship with EGFR in colorectal cancers.Methods: Immunohistochemical analysis of EMMPRIN and EGFR was performed in tissue microarray slides of 90 surgical specimens including 32 well differentiated, 35 moderately differentiated, and 23 poorly differentiated colorectal adenocarcinomas.Results: All colorectal adenocarcinomas showed significant immunohistochemical expression of EMMPRIN. The EMMPRIN scores in poorly differentiated (303 ± 21) and moderately differentiated (326 ± 17) colorectal adenocarcinoma were significantly higher than in well differentiated (166 ± 20) colorectal adenocarcinoma. EGFR expression was mainly on the cell surface of tumor cells and the immunostaining scores of EGFR were significantly associated with the advanced clinical T and N stages. A significantly positive relationship between EMMPRIN and EGFR immunostaining scores was also noted.Conclusions: Increased expression of EMMPRIN and EGFR in colorectal adenocarcinomas is associated with clinicopathological parameters of advanced colorectal adenocarcinoma stages.In addition, the data from this study support the notion that EGFR expression may up-regulate EMMPRIN expression.


2017 ◽  
Vol 16 (1) ◽  
pp. 9-15 ◽  
Author(s):  
Valeria Barresi ◽  
Luca Reggiani Bonetti ◽  
Antonio Ieni ◽  
Rosario Alberto Caruso ◽  
Giovanni Tuccari

2014 ◽  
Vol 146 (5) ◽  
pp. S-335
Author(s):  
Hector H. Li-Chang ◽  
Bojana Mitrovic ◽  
Kelly Handley ◽  
Richard Gray ◽  
Naziheh Assarzadegan ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (10) ◽  
pp. 2982 ◽  
Author(s):  
Paolo Giuffrida ◽  
Giovanni Arpa ◽  
Alessandro Vanoli ◽  
Antonio Di Sabatino

We read with interest the paper by Jun S [...]


EBioMedicine ◽  
2020 ◽  
Vol 57 ◽  
pp. 102860 ◽  
Author(s):  
Kenji Fujiyoshi ◽  
Juha P. Väyrynen ◽  
Jennifer Borowsky ◽  
David J. Papke ◽  
Kota Arima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document